BIOMERIEUX (EPA:BIM) | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Home
Companies
BIOMERIEUX

BRIEF

published on 12/04/2025 at 07:06, 23 hours 9 minutes ago

BioMérieux Introduces Equine Endocrinology Testing for Enhanced Horse Health

Veterinary Diagnostics Point Of Care Equine Health Endocrinology Tests BioMérieux Innovation
REGULATED PRESS RELEASE

published on 12/04/2025 at 07:01, 23 hours 14 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
bioMérieux launches endocrinology testing offer for equine health with VIDAS® Equine ACTH and INSULIN immunoassays

BioMérieux Veterinary Medicine Endocrinology Equine Health Immunoassay Tests
BRIEF

published on 12/02/2025 at 15:49, 2 days 14 hours ago

BioMérieux: Update on the number of shares and voting rights

Share Capital Voting Rights BioMérieux Actions Finance
BRIEF

published on 11/05/2025 at 07:06, 29 days 23 hours ago

Oxford Nanopore and bioMérieux Unveil AmPORE-TB for Drug-Resistant TB Analysis

BioMérieux Tuberculosis AmPORE-TB Oxford Nanopore Sequencing Technology
REGULATED PRESS RELEASE

published on 11/05/2025 at 07:01, 29 days 23 hours ago

Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only sequencing-based solution to rapidly characterize drug resistant-tuberculosis
Oxford Nanopore and bioMérieux launch AmPORE-TB, a Research Use Only solution for rapid characterization of drug resistant-tuberculosis, using nanopore sequencing technology

BioMérieux AmPORE-TB Oxford Nanopore Sequencing Technology Drug-resistant Tuberculosis
BRIEF

published on 11/04/2025 at 11:22, 1 month ago

Status of shares and voting rights at bioMérieux in October 2025

Share Capital Voting Rights Shares BioMérieux Financial Transparency
BRIEF

published on 11/04/2025 at 07:06, 1 month ago

BioMérieux Reports Solid Third-Quarter 2025 Performance

Product Innovation Organic Sales Growth Financial Forecast 2025 BIOFIRE® And SPOTFIRE® China Market Impact
REGULATED PRESS RELEASE

published on 11/04/2025 at 07:01, 1 month ago

bioMérieux – Third-Quarter 2025 Business Review
bioMérieux reports 7.3% organic sales growth in the first nine months of 2025, meeting annual guidance. Sales reach €2,992m driven by strategic plans. Full-year guidance updated

Financial Results BioMérieux Strategic Plan Organic Sales Growth Full-year Guidance
BRIEF

published on 10/02/2025 at 14:37, 2 months 2 days ago

BioMérieux: Status of shares and voting rights as of September 2025

Share Capital Voting Rights BioMérieux Actions September 2025
REGULATED PRESS RELEASE

published on 09/04/2025 at 07:15, 3 months ago

bioMérieux – First-Half 2025 Results

1 2 ... 9

Accesswire

Published on 12/05/2025 at 02:35, 3 hours 40 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 3 hours 45 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 5 hours 15 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 7 hours 10 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 7 hours 15 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 2 hours 45 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 6 hours 24 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 9 hours 50 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 10 hours ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 11 hours 5 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 12 hours 15 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 12 hours 30 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 12 hours 31 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 23 hours 14 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 12 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE